0001181431-12-052226.txt : 20120927
0001181431-12-052226.hdr.sgml : 20120927
20120927184327
ACCESSION NUMBER: 0001181431-12-052226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120925
FILED AS OF DATE: 20120927
DATE AS OF CHANGE: 20120927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adams Daniel
CENTRAL INDEX KEY: 0001328448
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 121114189
MAIL ADDRESS:
STREET 1: 501 SECOND STREET
STREET 2: SUITE 211
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
4
1
rrd356935.xml
SEPTEMBER 2012 -- EXERCISE AND SALE
X0306
4
2012-09-25
0
0001011835
MEDIVATION, INC.
MDVN
0001328448
Adams Daniel
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
1
0
0
0
Common Stock
2012-09-25
4
M
0
5000
6.97
A
5000
D
Common Stock
2012-09-25
4
S
0
5000
55.0017
D
0
D
Common Stock
2012-09-27
4
M
0
23038
6.97
A
23038
D
Common Stock
2012-09-27
4
M
0
60000
9.38
A
83038
D
Common Stock
2012-09-27
4
S
0
83038
55.7305
D
0
D
Stock Option (Right to Buy)
6.97
2012-09-25
4
M
0
5000
0.00
D
2018-06-15
Common Stock
5000
23038
D
Stock Option (Right to Buy)
6.97
2012-09-27
4
M
0
23038
0.00
D
2018-06-15
Common Stock
23038
0
D
Stock Option (Right to Buy)
9.38
2012-09-27
4
M
0
60000
0.00
D
2017-06-14
Common Stock
60000
0
D
Shares were sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $55.00 to $55.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option was previously reported but has been adjusted here to reflect the 2-for-1 stock split of the issuer's common stock that occurred on September 21, 2012.
Fully Vested
The shares were sold at prices ranging from $55.52 to $56.14. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Patrick Machado, Attorney-in-fact
2012-09-27